HSCs isolated from patients with NASH carrying the PNPLA3 I148M variant produce and release higher amounts of the chemokine CCL5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) than HSCs with wild-type PNPLA3. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.